Surgical resection of residual tumor after chemotherapy in non-seminomatous testicular cancer. 1982

R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger

Fifteen patients with disseminated non-seminomatous testicular cancer, 13 of whom had advanced disease, underwent surgery for residual tumor after induction chemotherapy. Complete remissions were achieved in 7 of 9 patients with mediastinal or pulmonary metastases and in 2 of 6 patients with retroperitoneal metastases. Patients with alpha-fetoprotein (AFP) levels over 10(4) ng/ml at diagnosis and/or a positive AFP preoperatively failed to achieve complete remission. Complete remissions were obtained in all 8 patients who had resection of necrosis, mature teratoma, immature teratoma or mature teratoma with malignant foci, but in only 1 of 7 patients who had resection of embryonal carcinoma or yolk sac tumor with other components. Of 9 patients with complete remission, 8 have remained free of disease after a median follow-up time of 29 months (range 6-66 months) and one had a contralateral non-seminomatous testicular cancer removed after 60 months. In addition to being therapeutically successful, the combined use of chemotherapy followed by surgery for residual tumor may lead to a better understanding of the influence of chemotherapy on the biology of testicular carcinoma.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008479 Mediastinal Neoplasms Tumors or cancer of the MEDIASTINUM. Cancer of Mediastinum,Mediastinal Cancer,Cancer of the Mediastinum,Mediastinum Cancer,Mediastinum Neoplasms,Neoplasms, Mediastinal,Cancer, Mediastinal,Cancer, Mediastinum,Cancers, Mediastinal,Cancers, Mediastinum,Mediastinal Cancers,Mediastinal Neoplasm,Mediastinum Cancers,Mediastinum Neoplasm,Neoplasm, Mediastinal,Neoplasm, Mediastinum,Neoplasms, Mediastinum
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins
D012186 Retroperitoneal Neoplasms New abnormal growth of tissue in the RETROPERITONEAL SPACE. Neoplasm, Retroperitoneal,Neoplasms, Retroperitoneal,Retroperitoneal Neoplasm
D013736 Testicular Neoplasms Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms. Cancer of Testis,Cancer of the Testes,Testicular Cancer,Testicular Neoplasm,Testicular Tumor,Testis Cancer,Cancer of the Testis,Neoplasms, Testicular,Neoplasms, Testis,Testicular Tumors,Testis Neoplasms,Tumor of Rete Testis,Cancer, Testicular,Cancer, Testis,Cancers, Testicular,Cancers, Testis,Neoplasm, Testicular,Neoplasm, Testis,Rete Testis Tumor,Rete Testis Tumors,Testicular Cancers,Testis Cancers,Testis Neoplasm,Testis Tumor, Rete,Testis Tumors, Rete,Tumor, Testicular,Tumors, Testicular

Related Publications

R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
January 1985, The British journal of surgery,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
April 2004, Critical reviews in oncology/hematology,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
December 2002, JPMA. The Journal of the Pakistan Medical Association,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
August 2018, Acta oncologica (Stockholm, Sweden),
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
May 2012, Aktuelle Urologie,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
January 2011, Urologia,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
January 1983, Urologia internationalis,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
January 2004, International braz j urol : official journal of the Brazilian Society of Urology,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
September 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R A Stahel, and A R Von Hochstetter, and F Largiadér, and O Schmucki, and H P Honegger
March 2002, Internal medicine journal,
Copied contents to your clipboard!